News
Gray, or gray market medications, are nothing new, and GLP-1s — the class of weight loss wonder drug that includes ...
Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a ...
Andy Richter said he looked into taking weight-loss drugs despite not having type 2 diabetes. However, his insurance company ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
In clinical trials, semaglutide proved to be superior to placebo, with weight loss reaching 15%, suggesting its superiority over other non-GLP-1 RA anti-obesity medications. Participants ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
2d
Her Campus on MSNWhat Gen Z College Students Need To Know About GLP-1s & Weight Loss SurgeryWeight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results